Correlation Between Immix Biopharma and Neximmune

Can any of the company-specific risk be diversified away by investing in both Immix Biopharma and Neximmune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immix Biopharma and Neximmune into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Immix Biopharma and Neximmune, you can compare the effects of market volatilities on Immix Biopharma and Neximmune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immix Biopharma with a short position of Neximmune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immix Biopharma and Neximmune.

Diversification Opportunities for Immix Biopharma and Neximmune

0.27

Correlation Coefficient

Immix Biopharma  Neximmune

Modest diversification

The 3 months correlation between Immix and Neximmune is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and Neximmune in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neximmune and Immix Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immix Biopharma are associated (or correlated) with Neximmune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neximmune has no effect on the direction of Immix Biopharma i.e., Immix Biopharma and Neximmune go up and down completely randomly.

Pair Corralation between Immix Biopharma and Neximmune

If you would invest  204.00  in Immix Biopharma on August 31, 2024 and sell it today you would lose (7.00) from holding Immix Biopharma or give up 3.43% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	1.59%
Values	Daily Returns

Immix Biopharma  vs.  Neximmune

Immix Biopharma

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Immix Biopharma are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak primary indicators, Immix Biopharma may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Neximmune

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neximmune has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Neximmune is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Immix Biopharma and Neximmune

The main advantage of trading using opposite Immix Biopharma and Neximmune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immix Biopharma position performs unexpectedly, Neximmune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neximmune will offset losses from the drop in Neximmune's long position.

The idea behind Immix Biopharma and Neximmune pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.